ロード中...
Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens
A two-step developability assessment workflow is described to screen variants of recombinant protein antigens under various formulation conditions to rapidly identify stable, aluminum-adjuvanted, multi-dose vaccine candidates. For proof-of-concept, a series of sequence variants of the recombinant no...
保存先:
| 出版年: | J Pharm Sci |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7884052/ https://ncbi.nlm.nih.gov/pubmed/33285182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2020.11.039 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|